Analysts with RBC Capital increased their price target of Boston Scientific to $20.
Ferring Pharmaceuticals and Institut Pasteur, a non-profit biomedical research center, are collaborating on the development novel drug development for the treatment of inflammatory bowel disease, according to a PMLive report.
EndoChoice named Scott Huennekens its chairman of the board.
http://www.endochoice.com/site/downloads/PR-15-009-1%20Scott%20Huennekens%20COB.pdf
Olympus warned European hospitals of infection risk linked to its TJF-Q180V duodenoscope approximately two years ago, but a similar warning was not released in the United States until recently.
Ritter Pharmaceuticals named Gerald T. Proehl the seventh member of its board of directors.
If you have a question, issue or note to suggest on a GI/endoscopy company please contact Carrie Pallardy at cpallardy@beckershealthcare.com.
More articles on gastroenterology:
2014 pay: 5 insights into gastroenterologist compensation
Mutare Health names Dr. Lawrence Kosinski CMO
How physician report cards improve colonoscopy quality: 4 things to know
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
